Malik Akhtar is Vice President at Bayer Consumer Health Division, where he oversees a network of 5000 suppliers, including direct materials, APIs, and 180 contract manufacturers.
Speaking on the PharmaSource Podcast, Malik explains the “Three C” procurement strategy which defines the areas of greatest focus for Bayer in 2024 and beyond:
<ul>
 <li>Cost Containment</li>
 <li>Cash-Flow improvement</li>
 <li>CO2 De-carbonisation</li>
</ul>
<a href="https://pharmasource.global/content/bayer-3c-procurement-strategy-for-2024-interview-with-malik-akhtar-vp-procurement/" target="_blank" rel="noopener noreferer">Read the interview here:</a>

Clinical Research and CROs in 2024: Insights from Scott Schliebner

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing.

In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides.

Make sure to subscribe for your regular dose of pharma insight.